dehydroepiandrosterone has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| SETNIKAR, I | 1 |
| Akamine, EH; Camporez, JP; Carvalho, CR; Davel, AP; Franci, CR; Rossoni, LV | 1 |
| Dhongade, HJ; Gidwani, B; Sahu, P | 1 |
1 review(s) available for dehydroepiandrosterone and cardiovascular agents
| Article | Year |
|---|---|
Pharmacological activities of dehydroepiandrosterone: A review.
Topics: Animals; Anti-Allergic Agents; Anti-Obesity Agents; Antineoplastic Agents, Hormonal; Cardiovascular Agents; Dehydroepiandrosterone; Humans; Hypoglycemic Agents | 2020 |
2 other study(ies) available for dehydroepiandrosterone and cardiovascular agents
| Article | Year |
|---|---|
[Pharmacological observations on dehydroepiandrosterone papaverine-3-monosulfate (DPMS)].
Topics: Cardiovascular Agents; Dehydroepiandrosterone; Muscle Relaxants, Central; Papaverine | 1963 |
Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats.
Topics: Acetophenones; Acetylcholine; Animals; Aorta, Thoracic; Cardiovascular Agents; Dehydroepiandrosterone; Endothelium, Vascular; Female; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Ovariectomy; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2011 |